CSI Market
Sign In | Register

Regeneron Pharmaceuticals Inc (REGN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access REGN Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Regeneron Pharmaceuticals Inc adapts its asset base and funding mix.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/REGN/balance-sheets
https://api.csimarket.com/api/v1/companies/REGN/fundamentals
https://api.csimarket.com/api/v1/companies/REGN/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent3,659.10
Restricted Cash12.50
Marketable Securities, Current SH5,642.00
Cash & Short-term Investments9,301.00
Accounts receivable7,578.60
Inventories2,894.60
Prepaid Expense And Other Assets Current1,020.80
Total Current Assets20,795.10
Intangible Assets1,315.50
Long-term investments9,557.40
Other Assets, Noncurrent12,737.20
Deferred Income Tax Assets Net4,190.90
Total Assets44,405.20
Liabilities
Accounts Payable, Current AC1,140.30
Accrued Liabilities And Other Liabilities3,592.00
Other Liabilities, Current1,469.80
Total Current Liabilities6,202.10
Long-term debt1,987.00
Total Long-term Debt1,987.00
Other liabilities, Noncurrent2,717.60
Deferred Revenue From Related Party Current720.00
Deferred Revenue Other Current636.20
Total Liabilities10,906.70
Stockholders' Equity
Additional Paid In Capital Common Stock15,172.70
Retained Earnings / Accumulated Deficit39,471.80
Accumulated Other Comprehensive Income-197.50
Other Equity-197.50
Common Stockholder's Equity33,498.50
Total Stockholder's Equity33,498.50
Liabilities & Stockholder's Equity44,405.20
4 historic quarters locked

Sign in to unlock the full Regeneron Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Regeneron Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000872589-26-000034

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI